GlassScriptPhysician profile
Philip Leung
NPI 1881686715
$6,548.22
in general payments reported to CMS, 2019-2025
43 companies · $1,077 in 2025
The $1,077 reported for 2025 was more than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $881 · 2020: $220 · 2021: $601 · 2022: $1,175 · 2023: $1,392 · 2024: $1,202 · 2025: $1,077.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,572 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,571.85 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $903.30 | 2019-2025 | Xywav |
| Glaxosmithkline, LLC. | $870.43 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $773.05 | 2019-2025 | Airsupra, Fasenra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $533.40 | 2019-2025 | Ofev, Spiriva Respimat, Jascayd |
| Inspire Medical Systems, INC. | $431.96 | 2023-2025 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $332.72 | 2023-2025 | Lumryz |
| Watermark Medical, INC. | $248.61 | 2022 | |
| Harmony Biosciences LLC | $224.04 | 2021-2025 | Wakix |
| Merck Sharp & Dohme LLC | $177.23 | 2019-2024 | Recarbrio, Zerbaxa, Dificid |
| Genzyme Corporation | $159.27 | 2019-2025 | |
| Ceribell, INC. | $151.51 | 2024 | Pocket Eeg Device |
| Insmed, INC. | $136.96 | 2019-2025 | Arikayce |
| Takeda Pharmaceuticals U.S.A., INC. | $131.79 | 2022-2025 | Cuvitru, Glassia |
| Baxter Healthcare | $126.27 | 2021-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Electromed, INC. | $117.06 | 2019-2023 | Smartvest |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $112.69 | 2019-2024 | Yupelri |
| Grifols USA, LLC | $107.51 | 2019-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $103.84 | 2021-2024 | Dupixent |
| Mallinckrodt Hospital Products INC. | $95.13 | 2022-2024 | Acthar |
| Philips North America LLC | $78.66 | 2019-2025 | Vest Therapy Und |
| Genentech USA, INC. | $72.97 | 2019-2025 | Xolair |
| Actelion Pharmaceuticals US, INC. | $60.03 | 2021-2022 | |
| Inogen, INC. | $50.10 | 2023-2025 | Inogen At Home Stationary Concentrator |
| United Therapeutics Corporation | $47.82 | 2022-2025 | Tyvaso |
| Amgen INC. | $46.36 | 2022 | |
| Pulmonx Corporation | $46.23 | 2022-2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Axsome Therapeutics, INC. | $42.69 | 2023-2024 | Sunosi |
| Alexion Pharmaceuticals, INC. | $34.35 | 2022-2023 | Ultomiris |
| Vapotherm INC | $33.67 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $31.01 | 2023 | Eliquis |
| Paratek Pharmaceuticals, INC. | $29.95 | 2022-2023 | Nuzyra |
| Circassia INC. | $29.50 | 2019 | |
| Ambu INC. | $26.59 | 2021 | |
| Pfizer INC. | $25.53 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.23 | 2019 | |
| Tactile Systems Technology INC | $22.42 | 2022 | |
| Viatris Specialty LLC | $20.41 | 2025 | Yupelri |
| Fisher & Paykel Healthcare INC | $17.49 | 2025 | Fisher & Paykel Healthcare |
| Hikma Pharmaceuticals USA | $16.76 | 2023 | Ryaltris |
| Ani Pharmaceuticals, INC. | $16.60 | 2024 | Purified Cortrophin Gel |
| Itamar Medical INC | $13.82 | 2023 | Watchpatone |
| Arbor Pharmaceuticals, INC. | $12.75 | 2019 | |
| Shire North American Group INC | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Leung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.